| 1 |
32776713 | Apoptotic and antihepatofibrotic effect of honokiol via activation of GSK3β and suppression of Wnt/β-catenin pathway in hepatic stellate cells. | 2021 Jan |
1 |
| 2 |
27064011 | Preclinical effects of honokiol on treating glioblastoma multiforme via G1 phase arrest and cell apoptosis. | 2016 May 15 |
4 |
| 3 |
27094504 | Combined effect of honokiol and rosiglitazone on cell growth inhibition through enhanced G0/G1 phase arrest in hepatoma cells. | 2016 Aug |
2 |
| 4 |
23221619 | Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo. | 2013 Jan |
1 |
| 5 |
21908486 | Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells. | 2011 Nov |
1 |
| 6 |
19135778 | Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells. | 2009 May 18 |
1 |
| 7 |
17938262 | Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity. | 2007 Oct |
3 |